Senapati J, Loghavi S, Garcia-Manero G, Tang G, Kadia T, Short NJ, Abbas HA, Arani N, DiNardo CD, Borthakur G, Pemmaraju N, Oran B, Shpall E, Popat U, Champlin R, Pierce S, Arora S, Issa G, Yilmaz M, Patel K, Takahashi K, Montalban-Bravo G, Hammond D, Haddad FG, Ravandi F, Kantarjian HM, Daver NG. Clinical interrogation of <i>TP53</i> aberrations and its impact on survival in patients with myeloid neoplasms. haematol [Internet]. 2025Jun.1 [cited 2025Jun.23];110(6):1304-15. Available from: https://haematologica.org/article/view/11870